Lessons From COVID-19: How Pharma Supply Chains Must Evolve Before Next Disaster
Experts describe the agile, localized supply chains that will emerge, only perhaps to be forgotten just-in-time for the next crisis.
You may also be interested in...
Expert outlines how pharma can create resilient and secure supply chains and some benefits of localization.
Gilead, Vetter, Lonza and academic experts share what they’re focusing on to keep producing drugs during the pandemic.
The groups on the front lines of the opioid epidemic may not be physicians or pharmacists or drug wholesalers, but they are the ones that need to receive naloxone if it is to do any good. Latest US FDA guidance removes one of the impediments.